Page 503 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux
P. 503
464 MÉDICAMENTS EN RELATION AVEC DES SYSTÈMES HORMONAUX
FAUSER B.C. The step-down principle in gonadotropin treatment and the rôle of Gn
RH analogues. Baillieres Clin. Obstet. Gynecol. 1993, 7 (2), 309-330.
GAGLIARDI C.L. Utility of gonadotropin-releasing hormone agonists in programs of
ovarian hyperstimulation with intrauterine insémination. Clin. Obstet. Gynecol.
1993, 36(3), 711-718.
GARCIA J.E. Gonadotropin-relasing hormone and its analogues : application in gyne-
cology. Clin. Obstet. Gynecol. 1993, 36 (3), 719-726.
GORDON K. et al. New trends in combined use of gonadotropin-releasing hormone
antagonists with gonadotropins of pulsatile gonadotropin-releasing hormone in
ovulation induction and assisted reproductive technologies. Curr. Opin. Obstet.
Gynecol. 1992, 4 (5), 690-696.
Guide national de prescription des médicaments. Editions du Vidal, Paris 1994.
HAMORI M. et al. Androgen response in polycystic ovarian syndrome to FSH treat
ment after LH RH agonist suppression. Int. J. Fertil. 1992, 37 (3), 171-175.
HANSCH C. Comprehensive médicinal chemistry. Pergamon Press, Oxford, 1990,
vol. 6.
HARING D.A. et al. Arcadius acephalus after induced ovulation : a case report.
Teratology, 1993, 47 (4), 257-262.
ITSKOVITZ E.J. ef al. Use of gonadotropin-releasing hormone agonist to cause ovula
tion and prevent the ovarian hyperstimulation syndrome. Clin, obstet. Gynecol.
1993,36(3), 701-710.
HARTEN M.J. ef al. Gonadotropin-releasing hormone analog design. Structure-
Fonction studies toward the development of agonists and antagonists : Rational
and perspective. Endocrine Reviews, 1986, 7 (1), 44-66.
LINDGREN B. et al. Pharmeuropa, 1993, (1).
MARCUS S.F. et al. Comparative trial between an ultra-short and long protocol of
luteinizing hormone-releasing hormone agonist for ovarian stimulation in, in vitro,
fertilization. Hum Reprod. 1993, 8 (2), 238-243.
MELDRUM D.R. Ovulation induction protocols. Arch. pathol. Lab. Med. 1992, 16 (4),
406-409.
MURSHER S.J. Use of gonadotropin-releasing hormone agonists in controlled ovarian
hyperstimulation for, in vitro, fertilization. Clin. Trier. 1992, 14, Suppl. A, 74-86.
NAKAMURA K. ef al. Menotropin stimulation after prolonged gonadotropin-releasing
hormone agonist pretreatment for, in vitro, fertilization in patients with endometrio-
sis. J. Assist. Reprod. Genet. 1992, 9 (2), 113-117.
PATTY J.R. Massive ovarian edema in a woman receiving clomifen citrate. A case
report. J. Reprod. Med. 1993, 38 (6), 475-479.
PENZIAS A.S. ef al. Nafarelin versus leuprolide in ovulation induction for, in vitro, ferti
lization : a randomized clinical trial. Obstet. Gynecol. 1992, 79 (5), 739-742.
SCHOOT D.C. ef al. Growth patterns of ovarian follicles during induction of ovulation
with decreasing doses of human menopausal gonadotropin following presumed
sélection in polycystic ovary syndrome. Fertil. Steril. 1992, 57 (5), 1117-1120.
SCHOOT D.C. ef al. Effects of gonadotropin releasing hormone agonist addition to
gonadotropin induction of ovulation in polycystic ovary syndrome patients. Eur. J.
Obstet. Gynecol. Reprod. Biol. 1992, 45 (1), 53-58.
TAN S.L. ef al. The use of luteinising hormone releasing hormone agonists for ovarian
stimulation in assisted reproductive technology. Am. Acad. Med. Singapore, 1992,
21 (4), 504-509.
TARLATZIS B.C. ef al. Ovarian stimulation with buserelin/HMG/HCG : prospective ran
domized study of short versus long protocol. Hum. Reprod., 1993, 8 (6), 807-812.
